![[Avant + Arrière] Kit d'ensemble roulement de roue et moyeu pour Mazda CX-5 KBB-111085 2001-mercury-cougar 2004 Subaru Forester KDA-100498](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/KBB-111085-01_2b87a8b4-4353-493d-a613-552b4c1772b4.jpg?v=1771451390)
[Avant + Arrière] Kit d'ensemble roulement de roue et moyeu pour Mazda CX-5 KBB-111085 2001-mercury-cougar 2004 Subaru Forester KDA-100498
EUR335.35EUR370.35
Pay in 4 interest-free payments of $83.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
Harbor notes
Description
[Avant + Arrière] Kit d'ensemble roulement de roue et moyeu pour Mazda CX 5 KBB 111085 2001 mercury cougar 2004 Subaru Forester KDA 100498 2004 Subaru Forester Pièces interchangeables OEM: 8906 9154 SS8906X AD8906 QE8906X D1736 1736 SCD1736 TEC D1736 7784 8405 8501 PF7784X SS7784X AD7784 QE7784X UP7784X D905 905 SCD905 TEC D905 Véhicules (consultez le tableau d'ajustement pour des informations détaillées sur le fitment): Produit: Kit d'ensemble roulement de roue et moyeu (Wheel Bearing and Hub Assembly Kit)
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant + Arrière] Kit d'ensemble roulement de roue et moyeu pour Mazda CX-5 KBB-111085 2001-mercury-cougar 2004 Subaru Forester KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.